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Boron neutron capture therapy (BNCT) is a targeted radio-
therapeutic modality used for the treatment of brain tumours and
melanoma in the USA, Europe and Japan. BNCT was extensively
reviewed in two recent articles (Barth et al, 1999; Coderre and
Morris, 1999). The targeting effectiveness of BNCT is dependent
upon the preferential delivery of boron-10 (10B) to the primary
tumour and its metastatic spread. A beam of thermalized neutrons
is used to ‘activate’ the 10B, with the resultant production of highly
localized high linear energy transfer (LET) radiation. This is due
to the capture of thermal neutrons by 10B with the resultant fission
reaction (10B + 1n® 11B® 7Li + 4He (a) + 2.79 MeV) giving rise to
high energy charged particles with short trajectories in tissue (5–
9 mm). The microlocation and differential accumulation of 10B will
therefore have a critical bearing on the therapeutic outcome of
BNCT, and also on the response of normal tissue in the irradiated
volume. In the clinical situation, relatively high therapeutic ratios
have been obtained enabling BNCT to be given as a single dose or
a small number (maximum 4) of dose fractions (Hatanaka et al,
1994; Coderre et al, 1997).
Mucositis is a commonly observed side-effect during conven-
tional radiotherapy for cancer of the head and neck. While acute
radiation damage of the oral mucosa is not generally associated
with the current treatment of gliomas using BNCT, a number of
patients involved in the American clinical studies are now
presenting with transient acute effects. The problem relates to
individuals with tumours at the front of the brain, in proximity to
mucosal tissue (Coderre et al, 1997). This finding suggests that
damage to the oral mucosa could be a potential complication in
future BNCT clinical protocols involving larger irradiation field
sizes than those in current use or multiple fields.
The purpose of the present investigation was to evaluate the
microdistribution of 10B in the oral mucosa, and relate this to the
biological effectiveness of the 10B(n,a)7Li neutron capture reaction
in this tissue. A CAMECA IMS-3f ion microscope, which is
essentially a direct imaging secondary ion mass spectrometer
(Benninghoven et al, 1987), was used to analyse cryopreserved
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Summary Clinical studies of the treatment of glioma and cutaneous melanoma using boron neutron capture therapy (BNCT) are currently
taking place in the USA, Europe and Japan. New BNCT clinical facilities are under construction in Finland, Sweden, England and California.
The observation of transient acute effects in the oral mucosa of a number of glioma patients involved in the American clinical trials, suggests
that radiation damage of the oral mucosa could be a potential complication in future BNCT clinical protocols, involving higher doses and larger
irradiation field sizes. The present investigation is the first to use a high resolution surface analytical technique to relate the microdistribution
of boron-10 (10B) in the oral mucosa to the biological effectiveness of the 10B(n,a)7Li neutron capture reaction in this tissue. The two boron
delivery agents used clinically in Europe/Japan and the USA, borocaptate sodium (BSH) and p-boronophenylalanine (BPA), respectively,
were evaluated using a rat ventral tongue model. 10B concentrations in various regions of the tongue mucosa were estimated using ion
microscopy. In the epithelium, levels of 10B were appreciably lower after the administration of BSH than was the case after BPA. The
epithelium:blood  10B partition ratios were 0.2:1 and 1:1 for BSH and BPA respectively. The 10B content of the lamina propria was higher than
that measured in the epithelium for both BSH and BPA. The difference was most marked for BSH, where 10B levels were a factor of six higher
in the lamina propria than in the epithelium. The concentration of 10B was also measured in blood vessel walls where relatively low levels of
accumulation of BSH, as compared with BPA, was demonstrated in blood vessel endothelial cells and muscle. Vessel wall:blood 10B partition
ratios were 0.3:1 and 0.9:1 for BSH and BPA respectively. Evaluation of tongue mucosal response (ulceration) to BNC irradiation indicated a
considerably reduced radiation sensitivity using BSH as the boron delivery agent relative to BPA. The compound biological effectiveness
(CBE) factor for BSH was estimated at 0.29 ± 0.02. This compares with a previously published CBE factor for BPA of 4.87 ± 0.16. It was
concluded that variations in the microdistribution profile of 10B, using the two boron delivery agents, had a significant effect on the response of
oral mucosa to BNC irradiation. From a clinical perspective, based on the findings of the present study, it is probable that potential radiation-
induced oral mucositis will be restricted to BNCT protocols involving BPA. However, a thorough high resolution analysis of 10B
microdistribution in human oral mucosal tissue, using a technique such as ion microscopy, is a prerequisite for the use of experimentally
derived CBE factors in clinical BNCT. © 2000 Cancer Research Campaign
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DOI: 10.1054/ bjoc.2000.1148, available online at http://www.idealibrary.com on tissue sections of the rat ventral tongue. This same instrument was
employed in a previous study (Smith et al, 1996) to assess 10B
microlocalization in a rat brain tumour model for BNCT. Ion
microscopy is a trace surface analytical technique with parts per
million (ppm) detection limits for 10B. In principal the CAMCA
IMS-3f can produce images of all isotopes from H to U with high
resolution. The optics of the ion microscope maintain the spatial
integrity of an analyte in a sample, producing images of isotopic
distributions which can be related to tissue morphology with a
resolution comparable to a conventional light microscope. A major
advantage of using the CAMCA IMS-3f ion microscope
for tissue microdistribution studies is the ability to observe and
quantify, in a single image, the concentration gradient of 10B in
multiple zones of tissue. The 10B distribution in the epithelium,
lamina propria and muscle of the oral mucosa can be viewed
simultaneously within a 150 mm diameter field of view.
The rat ventral tongue oral mucosa model, originally developed
by Morris and Coderre (Coderre et al, 1999; Morris et al, 1999),
was used in the present study. It is essentially a scaled up version
of the standard murine ventral tongue model used in radio-
biological studies (e.g. Moses and Kummermehr, 1986; Dorr and
Kummermehr, 1990). The larger tongue area of the rat facilitates
the jigging and shielding procedures required for local BNC irradi-
ation, thereby reducing the radiation burden to the head. In the
present study two boron delivery agents, borocaptate sodium
(BSH) and boronophenylalanine (BPA), were used in the evalua-
tion of 10B microdistribution in the tongue mucosa. The radio-
biological findings related to BSH-mediated BNC irradiation are
compared and contrasted with a previous report (Coderre et al,
1999) detailing the effects of BPA-mediated BNC irradiation on
the same model.
MATERIALS AND METHODS
All experimental procedures involved the use of male Fischer 344
rats aged 12 weeks (260–290 g). The animal studies were reviewed
and approved by the Brookhaven National Laboratory (BNL)
Institutional Animal Care and Use Committee. Rats were accom-
modated two to a cage in temperature controlled rooms and had
free access to food and water. They were maintained in a
controlled light/dark cycle, with lights on between 07:00 and
18:00 h.
Disodium mercaptoundecahydro-close dodecaborate (borocap-
tate sodium) containing 55.1% (certified weight percentage) 10B
with 95.8% enrichment (Centronic Ltd., Croydon, UK) was used
as the boron delivery agent. Vials of BSH powder, sealed under
nitrogen gas, were opened immediately prior to use. Dilution was
in sterile normal saline (10 mg BSH ml–1). Administration of the
BSH solution was by intraperitoneal (i.p.) injection in a volume of
1.5 ml (55 mg kg–1; 30 mg 10B kg–1). BPA was given i.p. in a
fructose solution at a dose of 700 mg kg–1 (34 mg 10B kg–1) as
described previously (Coderre et al, 1994). Concentrations of 10B
in solutions of BSH and BPA were determined using direct current
plasma atomic emission spectroscopy (DCP-AES) and prompt
gamma analysis (Fairchild et al, 1986; Barth et al, 1991).
Boron biodistribution
Boron concentrations in blood and tongue were measured using
(DCP-AES) and prompt gamma spectrometry.
The microdistribution of boron in the ventral tongue mucosa
was evaluated using ion microscopy. The ion microscopy analyses
were performed using a CAMECA IMS-3f ion microscope, a
direct imaging secondary ion mass spectrometer. The use of this
instrument for BNCT-related microlocalization studies has been
described previously (Smith et al, 1996). In the present study the
ion microscope was operated in the positive secondary ion
imaging mode with the samples biased to +4500 V. A mass-
filtered O2
+ primary ion beam accelerated to 10 keV was focused
and adjusted to a nominal beam current of 120 nA, producing a
stationary beam spot with a diameter of approximately 50 mm at
the surface of the sample. For all analyses, the primary ion beam
was raster scanned over 250 ´ 250 mm square regions. The rate of
erosion of the tissue specimens was approximately 20 Å per
second. Singly charged positive secondary ions, originating from
the surface of the sample, were collected as a global (non-mass-
filtered) image by the instrument’s immersion lens and focused
using the 150 mm transfer optics in conjunction with a 60 mm
contrast aperture. The energy window of the mass spectrometer
was centred and set to a maximum value of 130 eV. Energy and
mass filtered secondary ion images were magnified and projected
on a single microchannel plate/phosphor screen image detection
assembly. The gain of the microchannel plate was set to 73% of
maximum. Images were recorded directly from the image detec-
tion assembly using a Photometrics Ltd. CH220 charged-coupled
device (CCD) liquid-cooled camera head equipped with a
Thompson-CSF TH7882 CDA CCD camera digitized to 14 bits/
pixel by a photometric camera controller. For each region of
analysis, sequential ion images from 39K, 23Na, 10B, 12C, 24Mg and
40Ca were acquired with integration times of 0.2 s, 0.2 s, 2 min,
2 min, 30 s and 30 s respectively. The digitized ion images were
analysed using Alice™ 2.4.0 image processing software for the
Macintosh (Hayden Image Processing Group). Quantification of
the boron images was carried out using an ion microscopy calibra-
tion approach for biological specimens (Ausserer et al, 1989;Smith
et al, 1996). Estimates of the 10B concentration in the ventral
tongue mucosa were determined from pixel to pixel registration
and ratio of the 10B and 12C images, assuming an 85% tissue water
content.
Samples for ion microscopy imaging were cryogenically
prepared to preserve the in situ distribution of 10B and minimize
redistribution artefacts at the microscopic level. Two rats were
administered BSH at 30 min prior to anaesthesia and euthanasia.
Tissue specimens were frozen in liquid isopentane cooled to
–150°C in liquid nitrogen. Frozen sections, 4-mm-thick, were cut
perpendicular to the ventral surface of the tongue using a Reichert
HistoSTAT cryostat microtome operated at –20°C. Sections were
taken in series to correlate the tissue morphology (optical auto-
fluorescence microscopy) with 10B distribution (ion microscopy).
Sections prepared for optical imaging were mounted on glass
microscope slides and stained with haematoxylin and eosin.
Sections designated for ion microscopy imaging were mounted on
high purity indium/silicon substrates, freeze-dried for 24 h and
coated with a 400 Å thick layer of Au/Pd alloy to minimize sample
charging during analysis.
Dosimetry
Boron neutron capture (BNC) irradiations were carried out on the
thermal beam port of the Brookhaven Medical Research Reactor
Boron microlocalization in oral mucosa 1765
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consisted of thermal neutrons, fast neutrons, gamma rays and
charged particles (a,  7Li,  1H,  14C) from the 10B(n,a)7Li and
14N(n,p)14C neutron capture reactions were calculated using
thermal neutron fluence data from bare and cadmium-covered
gold foils and wires (secured to and inserted in the tongues of dead
rats). A uniform distribution of 2.7% w/w nitrogen in tissue was
assumed. Thermoluminescent dosimeters (TLD-700: Harshaw
Chemical, Solon, OH, USA) attached to the tongue, were used to
measure the gamma dose. The combined fast (>10 keV) neutron
and gamma doses at the beam port were measured using paired
tissue-equivalent (TE) plastic ionization chambers containing
methane-based tissue equivalent gas, and a graphite chamber filled
with carbon dioxide gas. The fast neutron dose rate was calculated
by subtraction of the gamma dose rate from the total dose rate.
Monte Carlo computation, normalized to the in-air neutron
dosimetry, was used to estimate the fast neutron dose rate at the
level of the ventral tongue mucosa.
The thermal neutron fluence at the surface of the tongue was
5.46 ´ 109 cm–2 s–1 with the reactor running at 1 MW power, using
a 10.2 cm thick collimator with a 20 mm diameter aperture. The
collimator was constructed of lithium carbonate (7.5%) dispersed
in polyethylene. The physical dose rates (cGy/MW min) were 2.84
(per mg10B g–1) for the 10B(n,a)7Li reaction; 9.9 for the fast neutron
interaction with hydrogen 1H(n,n)p; 7.0 for the nitrogen neutron
capture reaction (14N(n,p)14C); and 4.8 for the total gamma-ray
component (from the beam and induced in tissue by the 1H(n,g)2H
reaction).
Irradiations
Anaesthesia during irradiation was maintained by the i.p. injection
of ketamine (54 mg kg–1) and xylazine (9 mg kg–1). The anaes-
thetized rat was positioned in a body radiation shield (Joel et al,
1990; Morris et al, 1994a) that ensured that the rat was securely
supported during irradiation. The procedure for thermal beam and
BNC irradiation has been described in detail previously (Coderre
et al, 1999). Briefly, the tongue was secured with tape to the
20-mm diameter collimator and positioned to ensure uniform
irradiation of the ventral surface.
BSH was administered by i.p. injection 30 min prior to thermal
neutron irradiation. A 0.5 ml blood sample was taken immediately
prior to irradiation and the boron content determined using prompt
gamma analysis. On average, eight rats were irradiated per dose
group. The various dose groups are listed in Table 1. Radiation
reactions in the tongue were scored daily, under light carbon
dioxide/oxygen anaesthesia. Dose response was quantified using
ulceration as the end point.
The dose–effect curve for the incidence of ulceration were fitted
using probit analysis. The dose required to produce a 50%
incidence of ulceration (ED50) was calculated from this curve.
Errors indicate the standard error of the mean (± s.e.m.).
RESULTS
Boron biodistribution and microlocalization
Blood 10B concentrations from BSH for the various dose groups,
obtained immediately prior to irradiation, are given in Table 1. In
an additional evaluation of boron biodistribution (six rats) using
DCP-AES, levels of 10B in blood, ventral tongue and dorsal tongue
were 38.9 ± 1.8, 21.1 ± 0.4 and 17.1 ± 0.6 mg g–1 respectively.
The microdistribution of 10B in the ventral tongue mucosa was
evaluated using ion microscopy. The distributions of BSH and
BPA were compared and 10B concentrations were determined in
the epithelium, lamina propria and contiguous ventral tongue
muscle. Additionally, the boron accumulation characteristics of
BSH and BPA were compared in the walls of blood vessels.
An optical (autofluorescence) image of cryosectioned ventral
tongue mucosa of a rat administered BPA is shown in Figure 1A.
White arrows point to the smooth surface of the stratified squa-
mous epithelium which is generally not cornified on the lower
surface of the tongue. The dotted lines in panel 1A were drawn to
delineate the boundaries of the epithelium (Ep), the connective
tissue of the lamina propria (LP) and cross-sections of striated
muscle (M). The basal layer of the epithelium lies along the
boundary of the epithelium and the lamina propria. Cells which are
removed from the surface of the epithelium are replaced by cells
which move up from the basal layer. The basal layer is vulnerable
to radiation and damage manifests itself in this region. The circle
superimposed in the optical image is scaled to 150 mm in diameter
and correlates with the region on the adjacent cryosection analysed
with the ion microscope (Figure 1 B–D). Dotted lines in the ion
images of 10B, 24Mg and 12C (Figure 1 B–D) aid in visualizing the
histology of the oral mucosa. The white arrows in the ion images
point to the smooth surface of the epithelium. The ratio of the
white pixel density in the 10B and 24Mg ion images (Figure 1 B,C)
to the white pixel density of the 12C image (Figure 1D), is directly
proportional to the total concentration of boron and magnesium
respectively. The image of the tissue matrix, 12C, is used in the
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Table 1 Thermal beam exposure times, blood 10B content at the time of irradiation and physical absorbed doses for
the various treatment groups. Errors indicate ± s.e.m.
Thermal beam Blood 10B Thermal beam 10B(n,a)7Li
exposure time content dose component dose component Total dose
(MW min) (mg g)–1 (Gy) (Gy) (Gy)
7.5 43.6 ± 0.9 1.6 9.3 10.9
8.5 46.6 ± 3.0 1.9 11.2 13.1
9.5 41.5 ± 2.0 2.1 11.2 13.3
12.5 44.7 ± 2.3 2.7 15.9 18.6
14.0 44.3 ± 2.5 3.0 17.7 20.7
15.0 46.6 ± 4.2 3.3 19.8 23.1
16.5 43.3 ± 1.4 3.6 20.3 23.9Boron microlocalization in oral mucosa 1767
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quantification scheme to reduce potential errors associated with
the non-uniform response of the microchannel plate/phosphor
screen detection assembly of the ion microscope (Ausserer et al,
1989). Temporal degradation of the detection assembly is respon-
sible for the excessive brightness seen in the upper left and lower
right quadrants of the 10B, 24Mg and 12C images (black arrows). In
the absence of the 12C image, the white pixel intensity of the
epithelium in Figure 1B,C would be incorrectly interpreted as a
gradient with the highest concentrations of boron and magnesium
in the upper left and lower right quadrants.
Not shown are images of total 39K, 23Na and 40Ca. These
elements are imaged in sequence with 10B, 24Mg and 12C. Images of
39K, 23Na, 24Mg and 40Ca are relevant in assessing the physiological
status of the cryopreserved tissue. The ratio of the image intensi-
ties of 39K to 23Na from regions within the epithelium and muscle
were 3:1, indicating that the native distribution of these highly
diffusible species was not significantly altered. The ratio of the
image intensities of 39K to 23Na in the lamina propria falls off to
nearly 1:1 which is consistent with an area rich in blood vessels.
Blood has a relatively high sodium and low potassium content.
The 24Mg ion image (Figure 1C) shows a gradient of distribution
consistent with that observed for 39K and 23Na. The epithelium and
muscle had a high Mg content while the lamina propria had low
levels of Mg. As with K, the Mg content of blood is low relative to
the vessels and surrounding tissue.
Calcification (not shown) was limited to a thin layer at the
ventral surface of the tongue (white arrows in Figure 1 B,C) and
some extracellular spaces, the latter possibly due to some form of
calcium precipitate. Viable tissues were not excessively calcified,
indicating minimal damage due to sample preparation.
Sequential ion images of 24Mg and 10B from two regions of the
ventral tongue mucosa of a rat given BSH are shown in Figure 2.
The distribution of 24Mg in the epithelium, lamina propria and
muscle was similar to that observed after BPA administration. Mg
was high in the epithelium and muscle and low in the lamina
propria. Assessment of the physiological status of the cryopre-
served tissue based on the estimated concentrations of K, Na, and
Ca (images not shown) was also consistent with the pattern of
distribution observed in the BPA-treated rats. However, the distri-
bution pattern of 10B from BSH contrasts with that observed in the
tongues of rats treated with BPA. There were significantly reduced
concentrations of 10B in the epithelium and muscle relative to the
lamina propria and blood. The estimated 10B concentrations in the
various regions of the ventral tongue mucosa, after the administra-
tion of BSH and BPA are given in Table 2.
The values in Table 2 are reported as average 10B concentrations
for the individual histological features and are not subcellular
assignments. Although the CAMECA IMS-3f ion microscope is
operated to produce ion images with a nominal resolution of
~0.5 mm, the concentration gradient of 10B within the histological
features analysed was insufficient to resolve cellular boundaries.
Blood  10B levels were measured using DCP-AES and not ion
microscopy. This is due to the fact that the blood components of
arteries and vessels are often lost during cryogenic sample
Ep
LP
M 60 mm
A
Ep
LP
M
50 mm
B 10B
Ep
LP
M
50 mm
D 12C
Ep
LP
M
50 mm
C 24Mg
Figure 1 Ventral tongue mucosa of a rat administered BPA. (A) Autofluorescence-fluorescein isothiocyanate (FITC) photomicrograph of haematoxylin and
eosin stained cryosection of ventral tongue mucosa. The circle is scaled to 150 mm in diameter and correlates with the region of the adjacent cryosection of
tissue analysed with the ion microscope (see panels B–D). (B–D) Sequential ion images from a freeze-dried cryosection of tissue mounted on indium showing
the distribution of the isotopes 10B (B), 24Mg (C) and 12C (D). Images of 39K, 23Na and 40Ca are not shown. White arrows in (A–D) point to the outer surface of the
epithelium. Black arrows in (B–D) point to regions of excessive brightness caused by the non-uniform response of the microchannel plate/phosphor screen
detection assembly of the ion microscope. Dotted lines in (A–D) aid in visualization of the epithelium (Ep), lamina propria (LP) and muscle (M)1768 GM Morris et al
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preparation for ion microscopy. The 10B concentration in the
epithelium of BSH-treated rats was a factor of ~3.5 lower than that
found in the epithelium of BPA-treated rats. 10B was distributed
uniformly throughout the viable epithelium. Analysis of the basal
layer, which is the location of the epithelial stem cells, indicated
similar levels of 10B (P > 0.1, Student’s t-test) to that measured in
the entire viable epithelium (Table 2). The epithelium:blood 10B
partition ratios were 0.2:1 and 1:1 for BSH and BPA respectively.
In other words, levels of 10B in the epithelium were a factor of 5
lower than in the blood after BSH administration, but similar to
those in the blood after BPA administration. The lamina
propria:blood  10B partition ratio was 1:1 after the administration
of BSH and is consistent with a relatively high density of blood
vessels in this region. For BPA treated rats, the lamina
propria:blood  10B partition ratio was 1.5:1. The reason for the
higher levels of 10B in the lamina propria, as compared with the
blood, is not entirely clear. It may be related to the much broader
range of 10B concentrations obtained in the lamina propria after
BPA (8–75 mg g–1, 168 samples) as compared with BSH adminis-
tration. The concentration of 10B in muscle was a factor of ~1.3
lower than that in the blood of rats given BPA, but were a factor of
~5 lower than the blood in rats given BSH. The quantity of 10B in
blood vessel walls was relatively low (9.7 ± 1.3 mg g–1) after BSH
administration but was considerably higher (19.2 ± 1.6 mg g–1)
after BPA administration (Table 2).
Radiation response
The mean 10B concentrations in the blood, measured at the time of
irradiation, were used in the calculation of the physical radiation
dose from the 10B(n,a)7Li reaction. This resulted in a potential
variation in the total physical dose (which included the thermal
Figure 2 Ventral tongue mucosa of a rat administered BSH. Panels A, B and panels C, D are sequential ion images from different regions of analysis of a
freeze-dried cryosection of tissue on indium. (A, C) Ion images showing the distribution of the isotope 24Mg. (B, D) Ion images showing the distribution of the
isotope 10B. Images of 12C, 39K, 23Na and 40Ca are not shown. Dotted lines in panels A–D aid in visualization of the Ep, LP and M. For key to symbols refer to
Figure 1
LP
50 mm
A 24Mg
M
LP
50 mm
C 24Mg
Ep
LP
50 mm
B 10B
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M
50 mm
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Table 2 Measurement of 10B concentrations in ventral tongue mucosa using ion microscopy based direct imaging secondary ion mass
spectrometry (SIMS). Errors indicate ± s.e.m.
Boron Epithelium Lamina Muscle Blood Blooda
delivery propria vessel
agent wall
mg g–1 mg g–1 mg g–1 mg g–1 mg g–1
BSH 6.1 ± 1.0 36.2 ± 4.2 6.6 ± 0.6 9.7 ± 1.3 36.6 ± 6.4
b 5.8 ± 0.4
BPA 21.5 ± 0.5 31.1 ± 1.2 15.6 ± 1.7 19.2 ± 1.6 20.7 ± 0.7
b21.6 ± 0.4
a Blood 10B concentration was measured using DCP-AES. bBasal cell layer 10B concentration.Boron microlocalization in oral mucosa 1769
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beam dose) of ≤ 7.6%. Irradiation times were short (3–5 min)
because the BMR reactor was operated at full power (3 MW). As a
result, fluctuation in the 10B content of the blood was minimal over
the period of irradiation.
Ulceration of the ventral surface of the tongue was apparent by
7–8 days after irradiation with thermal neutrons in the presence of
BSH. The proportion of animals in which the tongue field exhib-
ited ulceration was dose dependent (Figure 3). Peak incidence of
ulceration was at 8–9 days after irradiation. Healing was rapid and
was completed by 8–11 days after irradiation. The dose-related
incidence of ulceration is shown in Figure 4. Previously published
data (Coderre et al, 1999) using the identical end point and strain
of rat are shown by way of comparison. ED50 values for the
ulceration end point were calculated from these curves. In defining
the biological effects of the 10B(n,a)7Li neutron capture reaction
relative to photons, the term compound biological effectiveness
(CBE) factor was used as an alternative to RBE. The rational
behind this has been discussed in detail previously (Morris et al,
1994). Calculation of the CBE is similar to that of the RBE factor.
Equating the X-ray ED50 dose with a BNC dose
(beam + BSH) that gives the same end point of a 50% incidenc
of ulceration produces the following equation:
CBE factor = [(X-ray ED50) – (thermal beam component of
ED50 ´ RBE)]/10B(n,a)7Li component of ED50.
In Figure 4 it is evident that the dose–effect curve for ulceration,
after BSH-mediated BNC irradiation, is shifted to the far right
indicating that this modality has a considerably reduced biological
effectiveness as compared with the thermal beam-only irradiation
modality or X-rays. Previously published ED50 values (Coderre et
al, 1999) for X-ray (13.4 ± 0.2 Gy) and thermal neutron beam
(BMRR) irradiation (4.2 ± 0.1 Gy), together with the thermal
beam RBE (3.2 ± 0.1), were used in the calculation of the CBE
factor for BSH. These were obtained using the same biological end
point in the identical strain, age and sex of rat to that used in the
present study. The ED50 for BSH mediated BNC irradiation was
calculated at 18.6 ± 1.0 Gy. Of this value, 2.8 Gy was from the
thermal beam and 15.8 Gy was from the 10B(n,a)7Li reaction.
Solving the above equation indicates a CBE factor for BSH of
0.29 ± 0.02.
DISCUSSION
In the present study, the end point used to evaluate the effects of
BNC irradiation on oral mucosa, was tongue ulceration. This is an
acute effect caused by radiation induced sterilization and death of
stem cells in the mucosal epithelium. Eventual denudation of the
epithelium leads to ulceration. The epithelium is therefore the
critical area for 10B analysis in the tongue mucosa. The initial
occurrence of tongue ulceration was at 7–8 days after irradiation
with thermal neutrons in the presence of BSH. This compares with
a latency to tongue ulceration of 6–8 days after irradiation with
X-rays, thermal beam – alone or in combination with BPA – using
the identical strain of rat (Coderre et al, 1999). For all irradiation
modalities, the time period over which tongue ulceration was
evident increased with increasing radiation dose. Comparable
findings have been documented by others using murine models.
In the case of ventral tongue, single exposures of 29 kV X-rays,
at doses in excess of 15 Gy, resulted in the development of ulcers
by days 9 and 10 (Moses and Kummermehr, 1986; Dorr and
Kummermehr, 1990). Mucositis was evident in mouse lips at 9 to
10 days after single dose irradiation with 250 kV X-rays or 60Co
(Parkins et al, 1983; Ang et al, 1984). In the clinic, fractionation
protocols involving irradiation over periods of 2 weeks or less
have resulted in the appearance of mucositis at 9–10 days after the
start of irradiation (Dutreix et al, 1971; Parkins et al, 1983; van der
Schueren et al, 1983). This suggests that the turnover time of
mucosal epithelium is comparable in the various rodent models
and man.
The dose contribution from the 10B(n,a)7Li reaction is routinely
calculated on the basis of the blood 10B concentration during the
course of thermal/epithermal neutron irradiation. No account is
taken of the 10B content of critical normal tissues in the irradiation
field in the dose calculations. This is because, at present, it is not
possible to estimate normal tissue concentrations of 10B during
the course of BNC irradiation. Non-invasive imaging techniques
are currently under development in an attempt to achieve this
objective (e.g. Kabalka et al, 1997; Imahori et al, 1998). The
physical dose delivered to a specific normal tissue is therefore
described in terms of the physical dose delivered to the blood.
As a consequence, the calculated CBE factor will be strongly
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Figure 3 Time-related changes in the incidence of tongue ulceration after
thermal neutron irradiation in the presence of BSH. The doses shown are
physical radiation doses. n = 10.9 Gy; l = 13.1 Gy; s = 13.3 Gy;
t = 18.6 Gy;  = 23.1 Gy; u = 23.9 Gy
Figure 4 Dose-related change in the incidence of tongue ulceration after
irradiation with thermal neutrons in the presence of BSH. Dose–effect curves
for the thermal beam-alone and X-rays are shown by way of comparison
(Coderre et al, 1999). The doses shown are physical radiation doses
n = thermal beam-alone; u = X-rays; l = thermal beam plus BSH1770 GM Morris et al
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influenced by variations in the amount of 10B present in the target
normal tissue relative to the blood (i.e. the 10B partition ratio). In
the present study, based solely on the 10B concentration of the
blood, the CBE factor for BSH was estimated at ~0.3. This
compares with a CBE estimate for BPA of ~4.9, using the identical
strain, sex and age of rat (Coderre et al, 1999).
RBE and CBE factors have been reported for skin, using moist
desquamation (epithelial denudation) as the end point. For thermal
beams, RBE values in the range 2.7–3.9 have been documented
(Yamamoto, 1961; Archambeau, 1989; Morris et al, 1994). A CBE
factor of ~2.5 has been estimated for both hamster and human skin
using BPA as the boron delivery agent (Hiratsuka et al, 1991;
Fukuda et al, 1994). A higher CBE estimate for BPA of ~3.7 was
reported using rat skin (Morris et al, 1994). The strain, age and sex
were identical to that employed in the present study. This suggests
that the oral mucosa (CBE ~4.9) is more sensitive to BPA-medi-
ated BNC irradiation than the skin. With BSH the CBE factor for
tongue mucosa was much lower at ~0.3. This value is comparable
with analogous CBE estimates (~0.4–0.5) for rat and dog skin
(Morris et al, 1994; Gavin et al, 1997).
Ion microscopy imaging studies of 10B in body tissues (Smith
et al, 1996, 1997), has enabled the biodistribution of this element
to be analysed with considerably greater precision than was previ-
ously possible. Although other analytical techniques have been
utilized for boron biodistribution studies, such as quantitative
neutron capture autoradiography (Gabel et al, 1987a) or the elec-
tron microprobe (Feldman and Mayer, 1986), they lack either the
spatial resolution or the sensitivity necessary to determine the
microdistribution of this trace analyte. Ion microscopy is
providing new insights into the relationship between 10B biodistri-
bution and the biological effectiveness of the high LET particles
produced by the 10B(n,a)7Li neutron capture reaction in vivo. Bulk
analysis (DCP-AES) of whole tissue samples from the ventral
tongue mucosa indicated appreciable uptake of 10B (~21 mg g–1)
after the administration of BSH. A similar finding was reported for
BPA administered at a comparable 10B concentration to BSH
(Coderre et al, 1999), where the level of 10B in the ventral tongue
was estimated at ~23 mg g–1. While this data indicated that the
overall concentrations of 10B in the tongue were similar for both
delivery agents, it provided no information with regard to the
biodistribution profile of the 10B in different regions of the tissue.
Ion microscopy analysis revealed that the level of 10B in the
mucosal epithelium was very low after BSH administration.
Indeed, the 10B content of the mucosal epithelium was ~3.5 times
higher in rats treated with BPA. In the case of BSH, the majority of
the  10B was located in the lamina propria. This differs from the
findings for BPA where the 10B content in the mucosal epithelium
was closer to that in the lamina propria, the differentials being 1:6
for BSH and 1:1.5 for BPA. Mucosal epithelium:blood 10B parti-
tion ratios were ~0.2 (6.2:36.6) and ~1 (21.5:20.7) for BSH and
BPA respectively. In other words, 10B accumulation in the epithe-
lium, relative to the blood, was 5 times higher with BPA than with
BSH. The physical dose (the blood dose) that resulted in a 50%
incidence (ED50) of ventral tongue ulceration was ~3.0 Gy using
BPA (Coderre et al, 1999) and ~18.6 Gy using BSH. When the
total radiation dose that was delivered directly to the mucosal
epithelium was estimated from the ion microscopy-derived 10B
concentrations, it was ~3.2 Gy and ~4.9 Gy for BPA and BSH
respectively. The CBE factor values calculated from these ED50s
were ~4.6 for BPA and ~2.2 for BSH. This indicates that a major
factor contributing to the difference in the CBE values (0.3 versus
4.9), estimated using blood 10B concentrations, was low uptake of
BSH by the mucosal epithelium. However, the fact that even
taking into account the 10B levels in the epithelium in radiation
dose calculations, the CBE factor for BPA was a factor of ~2
higher than for BSH suggests that the microdistribution of 10B
from these two compounds differs at the intracellular level.
The majority of the energy released after the capture of a
thermal neutron by a 10B atom (10B + n ® 11B ® 7Li + a + 2.79
MeV) is carried by the a and  7Li charged particles. Thus, as a
consequence, the pattern of energy deposition in critical cell
organelles, such as the nucleus is strongly influenced by the
microdistribution of the 10B atoms. Monte Carlo simulations have
demonstrated that 10B located in the cell nucleus is more effective
than 10B distributed in the cytoplasm, which is in turn more effec-
tive than boron attached to the cell membrane (Kobayashi and
Kanda, 1982; Gabel et al, 1987b; Verrijik et al, 1994). Thus, the
microlocalization of 10B has a critical effect on the biological
effectiveness of the 10B(n,a)7Li reaction. Monte Carlo simulations
for a cubic cell with a volume of 1150 mm3 and a spherical nucleus
of volume 230 mm3 (representative of a basal epithelial cell)
indicate a sevenfold reduction in efficacy when the 10B is located
exclusively extracellularly, and a fivefold increase in efficacy for
10B is located within the nucleus, as compared with the same
amount of 10B distributed homogeneously (Gabel et al, 1987b). At
the present time, data is not available on the precise microlocation
of 10B at the intracellular level for the mucosal epithelium. While
the resolution (~0.5 mm) of the ion microscope is sufficiently high
to evaluate the subcellular localization of 10B, it is not possible at
present to delineate the boundaries of individual epithelial cells in
tissue sections. For this reason, the subcellular microdistribution of
10B was not evaluated in the current study. The data presented
details the average concentration of 10B in the various histological
zones of the tongue mucosa, such as the mucosal epithelium. More
specific evaluation of the basal layer (the location of the stem
cells) revealed no appreciable difference in 10B content relative to
the higher suprabasal layers in the epithelium. This was true for
both BSH and BPA.
CONCLUSIONS
The ventral tongue mucosa of the rat was considerably less sensi-
tive to BSH as compared with BPA-mediated BNCT. This reduced
sensitivity was directly related to the microdistribution profile of
10B. At similar doses of 10B from BSH or BPA, the concentration of
this element was a factor of ~3.5 lower in the mucosal epithelium
after BSH as compared with BPA administration. At the present
time, due to practical considerations, CBE factors are estimated on
the basis of the radiation dose from the 10B(n,a)7Li neutron capture
reaction delivered to the blood. While this is a valid approach,
experimentally derived CBE factors from animal models must be
used in BNCT clinical dosimetry protocols with extreme caution.
The microdistribution profiles of 10B, for a given boron delivery
agent in a given tissue, must be comparable in the relevant animal
model and man for reliable extrapolation of the CBE factor.
Bulk analytical techniques, such as prompt gamma and DCP-
AES are routinely used for the intercomparison of 10B biodistribu-
tion in human and animal tissues. The findings of the present study
indicate that such an approach is inadequate, because no informa-
tion is provided on 10B accumulation in critical target cell compart-
ments. A major advance is offered by ion microscopy, which
facilitates the simultaneous analysis of 10B microdistribution andBoron microlocalization in oral mucosa 1771
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concentration at high resolution in individual tissue compartments,
such as the mucosal epithelium.
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